Max D. Tanaka
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Explaining increased locoregional failure following total neoadjuvant treatment in RAPIDO.
Journal: The British journal of surgery
Published: July 15, 2026
NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 26, 2025
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.
Journal: The British journal of surgery
Published: May 09, 2025
Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 13, 2024
Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial.
Journal: BMJ open
Published: June 15, 2023
Validated Pretreatment Prediction Models for Response to Neoadjuvant Therapy in Patients with Rectal Cancer: A Systematic Review and Critical Appraisal.
Journal: Cancers
Published: June 15, 2023
T1ρ for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study.
Journal: Journal of clinical medicine
Published: February 28, 2022
The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer.
Journal: Frontiers in endocrinology
Published: May 07, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026